Cerca studi clinici per: Vaccino COVID-19 ricombinante ad alto dosaggio (cellule Sf9) (18-59 anni) e regime a tre dosi
Totale 11 risultati
-
Jiangsu Province Centers for Disease Control and...West China HospitalCompletato
-
Jiangsu Province Centers for Disease Control and...Academy of Military Medical Sciences，Academy of Military Sciences，PLA ZHONGYIANKE...Reclutamento
-
WestVac Biopharma Co., Ltd.Non ancora reclutamento
-
National Vaccine and Serum Institute, ChinaChina National Biotec Group Company Limited; Lanzhou Institute of Biological... e altri collaboratoriReclutamentoInfezioni da coronavirus | Polmonite COVID-19Emirati Arabi Uniti
-
Guangzhou Patronus Biotech Co., Ltd.Yantai Patronus Biotech Co., Ltd.Attivo, non reclutante
-
Jiangsu Province Centers for Disease Control and...West China HospitalCompletato
-
Sinovac Research and Development Co., Ltd.Sospeso
-
Sinovac Research and Development Co., Ltd.Ritirato
-
Sinovac Life Sciences Co., Ltd.Completato
-
Jiangsu Province Centers for Disease Control and...Academy of Military Medical Sciences，Academy of Military Sciences，PLA; ZHONGYIANKE... e altri collaboratoriReclutamento
-
National Institute of Allergy and Infectious Diseases...Eunice Kennedy Shriver National Institute of Child Health and Human Development...CompletatoInfezioni da HIVStati Uniti, Porto Rico, Tailandia, Botswana, Argentina, Brasile, Tanzania, Sud Africa